STAT3 and breast carcinoma: In breast cancer, exposure to dim nighttime lighting (dLAN) disrupts the circadian rhythm of melatonin, which drives intrinsic resistance to paclitaxel through epigenetic mechanisms, increases STAT3 expression, and enhances breast tumors’ sensitivity to paclitaxel, inhibiting its growth (Xiang et al., 2019).